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Abstract
Background: Abnormalities of cardiac repolarization are a hallmark of Takotsubo cardio-
myopathy (TC), but their association with the occurrence of syncope and ventricular tachy-
arrhythmias is unknown. This study sought to assess the relationship between myocardial 
repolarization and malignant tachyarrhythmias in TC.
Methods: Clinical data and electrocardiographic repolarization parameters of 28 patients with 
TC and ventricular tachyarrhythmias (n = 26) or syncope (n = 2) were compared to data from 
20 randomly selected patients with TC but without ventricular tachyarrhythmias or syncope.
Results: Study patients had significantly lower ejection fraction (EF) compared with controls 
(35 ± 14% vs. 46 ± 10%, p = 0.006). On day 1, no significant differences in repolarization pa-
rameters were observed. However, in the subgroup with ventricular fibrillation ([VF]; n = 10),  
Tpeak-Tend in lead V6 was significantly prolonged (97 ± 20 vs. 85 ± 19 ms; p = 0.04).  
Similarly, in the subgroup with torsade de pointes ([TdP]; n = 5) Tpeak-Tend in lead V4 was 
prolonged (127 ± 21 vs. 94 ± 27 ms; p = 0.001). On day 3, Tpeak-Tend in lead V3 (130 ±  
± 51 vs. 105 ± 21 ms, p = 0.049) and Tpeak-Tend dispersion (56 ± 33 vs. 36 ± 21 ms;  
p = 0.03) were significantly longer in study patients. The difference in Tpeak-Tend in lead V3 
was borderline in the VF subgroup, but significant in the subgroup with TdP. The latter group 
had also longer Tpeak-Tend in lead V4 and longer corrected QT interval in leads V3 and V4.
Conclusions: Patients with TC who experience malignant tachyarrhythmias have lower  
EF and a more pronounced alteration of the spatial dispersion of ventricular repolarization. 
(Cardiol J 2013; 20, 6: 633–638)
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Introduction
Takotsubo cardiomyopathy (TC) is charac-
terized by transient left-ventricular wall motion 
abnormalities unrelated to significant coronary 
artery disease along with ECG abnormalities and/ 
/or elevation of cardiac troponin. Syncope and life-
-threatening ventricular tachyarrhythmias are rare 
but well known complications of the syndrome [1, 
2]. However, little is known about the risk factors 
that could lead to the development of malignant 
tachyarrhythmias. Several studies have found 
characteristic abnormalities of the ventricular re-
polarization [3, 4]. Whether there is an association 
between abnormal repolarization and occurrence of 
life-threatening tachyarrhythmias in TC remains 
unknown.
The aim of this study was to investigate the 
association of various parameters of myocardial 
repolarization with the development of malignant 
tachyarrhythmias in patients with TC.
Methods
Among 73 consecutive patients with a clinical 
diagnosis of TC at the University Medical Center 
Mannheim (UMCM), 9 were identified who either 
had an episode of ventricular tachyarrhythmia (n = 7) 
or whose initial presentation was an episode of 
syncope (n = 2). In January 2008 we also contacted 
7 authors who had previously published cases or 
case series with ventricular tachyarrhythmias in 
TC to contribute data from their published and, 
if available, from additional unpublished patients 
to the study. Overall, 5 authors contributed data 
from 20 patients with TC and malignant ventricular 
tachyarrhythmias [5–9]. Of these, 1 patient was 
excluded because of poor ECG quality that prohi-
bited further analysis. Finally, a total of 28 patients 
comprised the study cohort (group 1). Among 
the remaining 64 patients at the UMCM without 
ventricular tachyarrhythmias, 20 were randomly 
selected and served as controls (group 2). 
Diagnosis of TC was based on the Mayo Clinic 
criteria [10]: 1) Acute onset of mid-left-ventricular 
wall-motion abnormalities with or without apical 
involvement and not confined to the vascular terri-
tory of a single major coronary artery; 2) Absence 
of obstructive coronary disease or angiographic 
evidence of plaque rupture; 3) New ECG abnorma-
lities (either ST-segment elevation and/or T-wave 
inversion) or elevated cardiac troponin in the 
absence of pheochromocytoma, and myocarditis.
Resting 12-lead ECGs (50 mm/s, 1 mV/mm in 
German centers and 25 mm/s, 1 mV/mm in all other 
centers) on day 1 (day of the initial diagnosis) and 
day 3 were used to assess ventricular repolarisa-
tion. All measurements were performed manually 
and blinded to the patients’ clinical data. The QT 
intervals in each of the 12 leads were measured 
from the beginning of the QRS complex to the vi-
sual return of the T-wave to the isoelectric line for 
every patient. Where the T-wave was complicated 
by a U-wave, the end of the T-wave was defined as 
the nadir between the T- and U-wave [11]. T-waves 
smaller than 1 mm in amplitude were not measu-
red. The QT intervals were corrected for heart rate 
(QTc) using Bazett’s formula. The QT dispersion 
(QTD) for each ECG recording was defined as the 
difference between the longest and shortest me-
asured QT [12]. The Tpeak intervals (Tp) in each 
of the 6 precordial leads were measured from the 
beginning of the QRS complex to the peak of the 
T wave (if the T wave was positive) or to the nadir 
of the T wave (if the T wave was negative or bipha-
sic). The Tpeak-to-end interval (Tp-e) was derived 
from the equation: QT interval – Tp interval. The 
Tp-e dispersion (Tp-eD) was defined as the diffe-
rence between the longest and shortest measured 
Tp-e [13]. All measurements were averaged for 
2 consecutive beats in patients with sinus rhythm 
and for 3 consecutive beats in atrial fibrillation. 
Intra-observer and inter-observer variability was 
assessed in 20 randomly selected ECGs. 
Review of these data was approved by the local 
review board.
Statistical analysis
Continuous variables are expressed as mean ± 
± standard deviation. Continuous variables were 
compared using the unpaired student t test or 
Mann-Whitney U test. Categorial variables were 
compared with the c2 test or Fisher exact test. 
To assess colinearity or independency of lower 
left ventricular ejection fraction (EF) and Tp-e 
variables, Spearman’s rank correlation coefficients 
were calculated. A p value < 0.05 was considered 
statistically significant.
Results
The clinical features of patients are shown in 
Table 1. Baseline parameters were similar between 
both groups except for EF which was significantly 
lower in patients with malignant tachyarrhythmias 
(35 ± 14% vs. 46 ± 10%, p = 0.006). Overall, the 
following tachyarrhythmias were observed: Non-
-sustained ventricular tachycardia in 8, ventricular 
tachycardia (VT) in 3, ventricular fibrillation (VF) 
in 4, torsade de pointes (TdP) in 4, both VT and 
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VF in 6 and both VT and TdP in 1 patient. Events 
occurred on day 1 in 24 patients (86%). In 1 patient, 
episodes of VT and VF occurred on days 4, 7 and 8. 
One patient had an episode of TdP on day 6 and 
recurrent episodes of VT on day 9. Non-sustained 
ventricular tachycardia occurred on day 4 in 1 pa-
tient and on day 5 in another.
QTc increased significantly from day 1 to day 3, 
both in group 1 (450 ± 32 vs. 487 ± 52 ms, p = 
= 0.004) and in group 2 (449 ± 31 vs. 485 ± 33 ms, 
p < 0.001) as did Tp-e (group 1: 89 ± 18 vs. 121 ± 
± 38 ms, p < 0.001; group 2: 82 ± 16 vs. 142 ± 28 ms, 
p < 0.001). Heart rate decreased significantly from 
day 1 to day 3 (group 1: 84 ± 19 vs. 74 ± 15 bpm, 
p = 0.04; group 2: 99 ± 16 vs. 85 ± 20 bpm, 
p = 0.02). QTD and Tp-eD did not change signi-
ficantly from day 1 to day 3. Intra-observer and 
inter-observer variability were 15 ± 31 and 19 ± 
± 33 ms, respectively. Combined Tp-e values and 
Tp-e values within groups at day 1 and day 3 did 
not reveal any correlation with EF (each p = NS).
Repolarization parameters on day 1
On day 1, no significant differences were ob-
served for various repolarization parameters be-
tween group 1 and group 2 (Table 2). However, when 
only patients with an episode of VF (n = 10) were 
analyzed, Tp-e in lead V6 was significantly prolonged 
(Table 3). Similarly, subgroup analysis of patients 
with TdP (n = 5) revealed significantly greater Tp-e 
in lead V4 in this subset of patients (Table 3).
Compared with controls, heart rates were 
significantly lower in group 1 patients (Table 2). 
This was predominantly caused by low heart rates 
in the subgroup of patients with TdP whose heart 
rates were significantly lower than heart rates in 
the remainder of group 1 (67 ± 12 vs. 87 ± 18 ms, 
p = 0.03) or heart rates in group 2 (67 ± 12 vs. 
99 ± 16, p < 0.001).
Repolarization parameters on day 3
On day 3, there were significant differences 
between group 1 and group 2 with regard to heart 
rate, Tp-e in lead V3 and Tp-eD (Table 2). Subgroup 
analysis of patients with VF revealed no significant 
differences for heart rate and borderline signifi-
cance for Tp-e in lead V3. Tp-eD was significantly 
higher in group 1. Subgroup analysis of patients 
with TdP demonstrated significant differences for 
several parameters including heart rate, QTc in 
lead aVL, QTc in lead V3, QTc in lead V4, Tp-e in 
lead V3 and Tp-e in lead V4 (Table 3). 
Discussion
Abnormalities of cardiac repolarization are 
a hallmark of TC and were observed as early as 1990 
when, for the first time, Sato et al. [14] reported 
on this disease entity. Despite this, the incidence 
of malignant ventricular arrhythmias in TC seems 
to be rather low ranging from 1% to 9% in several 
large series of patients with the disease [15–18]. 
Previous reports have shown characteristic 
changes in the 12-lead ECG in TC. Matsuoka et 
al. [4] examined the time course of the ECG in 10 
consecutive patients. All patients had ST segment 
elevation upon presentation and developed T-wave 
inversions in several leads on the following days 
(“subacute phase”). Takashio et al. [19] reported 
that the electrocardiographic extent and magnitude 
of ST-segment elevation are potentially useful 
predictors of in-hospital complications in patients 
presenting with TC.
Maximum QT interval, minimum QT interval, 
QTc, QTD, heart rate-corrected QTD, and Tp-e 
Table 1. Baseline characteristics.
Group 1 Group 2 P
Age [years] 63 ± 15 67 ± 11 0.37
Women 24 (86%) 19 (95%) 0.38
Men 4 (14%) 1 (5%)
Variant of Takotsubo cardiomyopathy:
Apical 25 (89%) 15 (75%) 0.25
Midventricular 2 (7%) 5 (25%) 0.11
Basal 1 (4%) 0 (0%) 1
Troponin [µg/L] 5.8 ± 6.6 3.2 ± 4 0.13
Ejection fraction [%] 35 ± 14 46 ± 10 0.006
Survival to discharge 26 (93%) 20 (100%) 0.37
636 www.cardiologyjournal.org
Cardiology Journal 2013, Vol. 20, No. 6
were all significantly prolonged during the “subacu-
te phase” of the disease. Kurisu et al. [3] examined 
the time course of the ECG in 16 patients. They 
observed that the QT interval as well as the depth 
of the T-wave had a 2-peaked time course, one 
occurring around days 2–3 and the other one occur-
ring between days 14–21. Bonnemeier et al. [20], 
in a case control study, demonstrated that patients 
with TC, unlike patients with reperfused anterior 
myocardial infarction, continue to show modulation 
of the QT interval with changes in the heart rate.
So far, only one study has systematically ana-
lysed malignant arrhythmias in TC [21]. Out of 
105 patients with TC at the Mayo Clinic, 6 were 
identified who had experienced either VF (n = 3) 
or significant bradyarrhythmias (n = 3). The stu-
dy group was compared to 31 randomly selected 
control patients with TC but without arrhythmias. 
When compared with controls, the study patients 
had higher R-R interval variability (maximal R-R 
interval – minimal R-R interval in the first 24 h 
of admission) and longer QTc. PR interval was 
also longer in the study group, but the difference 
disappeared, once the PR interval was corrected 
for the heart rate. The authors also found that all 
patients in the study group had a history of atrial 
arrhythmias (n = 5) or atrio-ventricular nodal dys-
function (n = 1). However, in that study the small 
number of patients and the heterogeneous nature of 
observed arrhythmias precluded firm conclusions.
To our knowledge, this is the largest series 
of patients with malignant tachyarhythmias in TC. 
Similar to what is known from many other cardiac 
diseases, patients with malignant tachyarrhythmias 
had significantly lower EF compared to controls. 
This difference remained significant even after 
excluding those 5 patients whose presenting symp-
tom had been a cardiac arrest and who, therefore, 
might have had some degree of cardiac arrest-
-related myocardial stunning.
In accordance with previous reports, QTc 
increased significantly during the first few days 
following diagnosis of TC. In contradistinction to 
a previous report [21], however, mean QTc did not 
Table 2. Repolarisation parameters of the entire study population.
Parameter Day 1 Day 3
Group 1  
(n = 28)
Group 2  
(n = 20)
P Group 1  
(n = 28)
Group 2  
(n = 20)
P
Heart rate [bpm] 84 ± 19 99 ± 16 0.009 74 ± 15 85 ± 21 0.048
QTc I [ms] 441 ± 41 443 ± 27 0.83 492 ± 52 488 ± 39 0.76
QTc II [ms] 447 ± 39 442 ± 39 0.73 476 ± 59 477 ± 41 0.99
QTc III [ms] 422 ± 98 443 ± 45 0.42 487 ± 55 475 ± 46 0.48
QTc aVR [ms] 454 ± 39 444 ± 33 0.39 489 ± 55 490 ± 46 0.97
QTc aVL [ms] 441 ± 45 443 ± 49 0.92 496 ± 54 471 ± 43 0.12
QTc aVF [ms] 452 ± 40 448 ± 42 0.72 474 ± 59 467 ± 37 0.69
QTc V1 [ms] 439 ± 50 447 ± 45 0.57 466 ± 54 477 ± 46 0.52
QTc V2 [ms] 439 ± 39 456 ± 39 0.17 490 ± 65 494 ± 43 0.78
QTc V3 [ms] 452 ± 37 451 ± 33 0.92 499 ± 70 492 ± 43 0.71
QTc V4 [ms] 454 ± 38 453 ± 41 0.90 513 ± 62 502 ± 35 0.5
QTc V5 [ms] 458 ± 38 458 ± 34 0.99 496 ± 63 496 ± 38 0.99
QTc V6 [ms] 458 ± 33 445 ± 31 0.20 494 ± 65 484 ± 39 0.56
QTc mean [ms] 450 ± 32 448 ± 31 0.87 449 ± 75 485 ± 32 0.09
QT dispersion [ms] 66 ± 29 60 ± 23 0.37 79 ± 44 65 ± 26 0.24
Tp-e V1 [ms] 79 ± 23 80 ± 24 0.80 118 ± 43 96 ± 46 0.15
Tp-e V2 [ms] 87 ± 23 93 ± 27 0.81 118 ± 40 109 ± 42 0.47
Tp-e V3 [ms] 84 ± 17 94 ± 27 0.14 130 ± 51 105 ± 21 0.049
Tp-e V4 [ms] 85 ± 17 94 ± 27 0.21 131 ± 42 114 ± 28 0.12
Tp-e V5 [ms] 83 ± 20 88 ± 19 0.22 123 ± 48 108 ± 29 0.22
Tp-e V6 [ms] 78 ± 22 85 ± 19 0.17 120 ± 42 102 ± 25 0.08
Tp-e mean [ms] 83 ± 15 97 ± 21 0.21 121 ± 38 141 ± 28 0.09
Tp-e dispersion [ms] 36 ± 16 42 ± 18 0.25 56 ± 33 36 ± 21 0.041
QTc — corrected QT interval; Tp-e — Tpeak-to-end interval
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differ significantly between study patients and con-
trols. This was also true for the subset of patients 
with TdP in whom one would intuitively expect 
particularly long QTc intervals. Our findings con-
cur with observations made by Samuelov-Kinori 
et al. [22]. In their recently published study, the 
authors compared 15 patients with TC-associated 
TdP from published reports with 86 patients from 
published reports who had TC-associated QT in-
terval prolongation without TdP. They found that 
when compared to patients without TdP, patients 
with TdP had only a trend towards longer QTc 
intervals which did not reach statistical significan-
ce. Of note, although mean QTc in our study did 
not differ between patients and controls, QTc in 
several single leads (aVL, V3 and V4) was signifi-
cantly longer in patients with TdP, indicating the 
possibility of significant regional heterogeneity of 
the QT interval in TC. This could be explained by 
a disease process that affects the myocardium in 
a non-uniform manner. Importantly, patients with 
TdP had significantly lower heart rates, when 
compared to other study patients or to controls, 
indicating a potential role of low heart rates in the 
occurrence of TdP.
Changes of the Tp-e interval are thought 
to be capable of reflecting changes in the spa-
tial dispersion of repolarization, and thus may 
be prognostic of arrhythmic risk in a variety of 
different cardiac pathologies [23], including TdP 
during acquired bradyarrhythmias [24] and VT in 
coronary artery disease [25]. An extensive review 
of this concept has been published elsewhere 
[23]. As transmural dispersion of repolarization 
can be highly variable in different myocardial 
regions, it is important to analyse Tp-e in each 
of the precordial leads independently and not to 
average them across several leads [23]. By do-
ing so, we found significant differences in single 
leads among different subgroups of patients and 
at different time points. For example, patients 
with TdP had prolonged Tp-e in lead V4 on day 1 
and prolonged Tp-e in leads V3 and V4 on day 3, 
whereas patients with VF had only prolonged 
Table 3. Repolarization parameters by subgroups.











Group 2  
(n = 20)
Heart rate [bpm] 91 ± 24 63 ± 6* 99 ± 16 81 ± 17 62 ± 11* 85 ± 21
QTc I [ms] 439 ± 30 453 ± 60 443 ± 27 480 ± 62 521 ± 74 488 ± 39
QTc II [ms] 460 ± 39 449 ± 51 442 ± 39 484 ± 62 487 ± 105 477 ± 41
QTc III [ms] 372 ± 155 445 ± 27 443 ± 45 482 ± 63 500 ± 63 475 ± 46
QTc aVR [ms] 456 ± 34 460 ± 43 444 ± 33 480 ± 53 545 ± 75 490 ± 46
QTc aVL [ms] 425 ± 62 450 ± 30 443 ± 49 501 ± 66 550 ± 54* 471 ± 43
QTc aVF [ms] 452 ± 51 466 ± 57 448 ± 42 461 ± 61 – 467 ± 37
QTc V1 [ms] 433 ± 42 469 ± 24 447 ± 45 460 ± 57 510 ± 68 477 ± 46
QTc V2 [ms] 439 ± 39 460 ± 31 456 ± 39 483 ± 82 525 ± 76 494 ± 43
QTc V3 [ms] 455 ± 39 463 ± 39 451 ± 33 497 ± 85 566 ± 28* 492 ± 43
QTc V4 [ms] 464 ± 38 468 ± 46 453 ± 41 515 ± 69 569 ± 34* 502 ± 35
QTc V5 [ms] 459 ± 41 471 ± 48 458 ± 34 497 ± 74 539 ± 60 496 ± 38
QTc V6 [ms] 465 ± 36 465 ± 44 445 ± 31 476 ± 71 533 ± 84 484 ± 39
QTc mean [ms] 450 ± 34 461 ± 36 448 ± 31 481 ± 55 522 ± 74 485 ± 32
QT dispersion [ms] 65 ± 17 60 ± 37 60 ± 23 86 ± 57 58 ± 31 65 ± 26
Tp-e V1 [ms] 105 ± 30 75 ± 7 80 ± 24 120 ±50 120 ± 66 96 ± 46
Tp-e V2 [ms] 101 +/ -28 75 ± 39 93 ± 27 125 ± 51 113 ± 62 109 ± 42
Tp-e V3 [ms] 97 ± 30 95 ± 44 94 ± 27 136 ± 60* 180 ± 62* 105 ± 21
Tp-e V4 [ms] 97 ± 27 127 ± 21* 94 ± 27 136 ± 45 163 ± 47* 114 ± 28
Tp-e V5 [ms] 90 ± 20 95 ± 26 88 ± 19 138 ± 52 148 ± 69 108 ± 29
Tp-e V6 [ms] 97 ± 20* 88 ± 15 85 ± 19 118 ± 50 143 ± 64 102 ± 25
Tp-e mean [ms] 95 ± 27 93 ± 28 97 ± 21 128 ± 46 134 ± 64 141 ± 28
Tp-e dispersion [ms] 39 ± 17 50 ± 22 42 ± 18 59 ± 32* 50 ± 29 36 ± 21
*p < 0.05 vs. Group 2; QTc — corrected QT interval; TdP — torsade de pointes; Tp-e — Tpeak-to-end interval; VF — ventricular fibrillation
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Tp-e in lead V6 on day 1. This could indicate that 
patients with malignant arrhythmias have a more 
pronounced spatial dispersion of repolarization 
than patients who do not experience these types 
of arrhythmias. Additionally, the spatial dispersion 
of repolarization seems to be dynamic in nature.
QTD, which is believed to be a crude and 
indirect measure of general repolarization abnor-
malities [26], did not differ significantly between 
study patients and controls. However, QTD values 
in both groups seem to be higher than what has 
been reported in healthy individuals where QTD 
varies mostly between 30 and 60 ms [26].
Limitations of the study
This was a retrospective study, and thus some 
data relevant to malignant tachyarrhythmias may 
have not been collected at the time of diagnosis. 
Furthermore, the small number of patients in 
different subgroups limits the interpretation of 
subgroup data.
Manual measurements of repolarization in-
tervals can be unreliable. This is particularly due 
to the uncertainties associated with the manual 
determination of the T-wave offset. The number 
of measurable leads in the 12-lead ECG can also 
significantly influence the range of QT and Tp-e 
interval durations, and thus can be a significant 
source of error.
Conclusions
In summary, patients with TC who experience 
malignant tachyarrhythmias have lower EF and 
a more pronounced alteration of the spatial disper-
sion of ventricular repolarization. Whether or not 
there is a true cause-effect relationship between 
abnormal repolarization and occurrence of malig-
nant tachyarrhytmias in TC, however, remains to 
be seen.
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